Separate powers, singular purpose: How Congress, the Executive, and the courts are revolutionizing pharmaceutical patent litigation

被引：0

|

作者：

Ray, Chad ^{[1
]}

机构：

[1] Jenner & Block, Chicago, IL USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2015年 / 249卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

35

引用

收藏

页数：1

相关论文

共 4 条

[1] PATENT LITIGATION REFORM: THE COURTS, CONGRESS, AND THE FEDERAL RULES OF CIVIL PROCEDURE
Gugliuzza, Paul R.
[J]. BOSTON UNIVERSITY LAW REVIEW, 2015, 95 (01) : 279 - 301
[2] How Fair is Patent Litigation in China? Evidence from the Beijing Courts
Zhang, Chenguo
Cao, Jin
[J]. CHINA QUARTERLY, 2020, 241 : 247 - 261
[3] THE CIVIL-RIGHTS-ACTS-OF-1991 - FROM CONCILIATION TO LITIGATION - HOW CONGRESS DELEGATES LAWMAKING TO THE COURTS
HERNICZ, CB
[J]. MILITARY LAW REVIEW, 1993, 141 : 1 - 82
[4] Policy Reversal on Reverse Payments: Why Courts Should Not Follow the New DOJ Position on Reverse-Payment Settlements of Pharmaceutical Patent Litigation
Butler, Henry N.
Jarosch, Jeffrey Paul
[J]. IOWA LAW REVIEW, 2010, 96 (01) : 57 - 125